Researchers Encourage More Chlamydia Screening

JANUARY 01, 2005

The reasons for more thorough chlamydia screening are 2-fold. A study, reported in the Annals of Internal Medicine (October 5, 2004), found that more comprehensive screening would likely reduce the frequency of the disease and be cost-effective.

In the study, the researchers found that screening women under the age of 30, and suggesting that any woman who had chlamydia be tested every 6 months rather than only once after diagnosis, would raise health care costs by $107 per woman but would prove cost-effective down the line. "When you take into account the positive effects of screening—not only for the women themselves, but also the benefits from avoiding transmission of the disease to babies or to men—screening becomes cost-saving," said Delphine Hu, MD, PhD, study author.

Dr. Hu explained that the reason for testing relatively older women for the disease reflects current trends: women are marrying later in life and thus have a longer period of sex partners, which increases their risk for chlamydia. Also, screening women every 6 months after they have had chlamydia is wise because those who have had it are 2 times as likely to have a recurrence, compared with those who have never had the disease.


Become A RESPIMAT T.O.P. Performer 

Get to know RESPIMAT, the slow-moving mist inhaler from Boehringer Ingelheim Pharmaceuticals, Inc.

Watch the RESPIMAT video and test your knowledge with a short multiple-choice quiz. When you get all the answers right, you’ll receive a certificate naming you a RESPIMAT T.O.P. Performer. Why not check it out today?

Pharmacy Times Strategic Alliance

Pharmacist Education
Clinical features with downloadable PDFs

Next-Generation Pharmacist® Awards

3rd Annual Convenient Healthcare and Pharmacy Collaborative Conference

Personalize the information you receive by selecting targeted content and special offers.